Shares

54 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$73.17 - $99.79 $22,682 - $30,934
-310 Reduced 8.85%
3,194 $302,000
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $8,864 - $12,474
189 Added 5.7%
3,504 $175,000
Q1 2023

May 15, 2023

SELL
$37.97 - $50.0 $13,745 - $18,100
-362 Reduced 9.84%
3,315 $149,000
Q4 2022

Jun 14, 2023

BUY
$41.06 - $66.48 $14,863 - $24,065
362 Added 10.92%
3,677 $161 Million
Q3 2022

Jun 14, 2023

BUY
$49.93 - $77.7 $18,074 - $28,127
362 Added 10.92%
3,677 $242 Million
Q2 2022

Jun 20, 2023

BUY
$45.23 - $70.15 $16,373 - $25,394
362 Added 10.92%
3,677 $185,000
Q1 2022

Jun 20, 2023

BUY
$54.1 - $110.08 $19,584 - $39,848
362 Added 10.92%
3,677 $234,000
Q1 2022

Mar 30, 2023

SELL
$54.1 - $110.08 $606,731 - $1.23 Million
-11,215 Reduced 75.31%
3,677 $234,000
Q1 2022

May 12, 2022

SELL
$54.1 - $110.08 $606,731 - $1.23 Million
-11,215 Reduced 75.31%
3,677 $235,000
Q4 2021

Jun 21, 2023

BUY
$94.25 - $115.99 $1.09 Million - $1.34 Million
11,577 Added 349.23%
14,892 $1.6 Million
Q4 2021

Mar 30, 2023

SELL
$94.25 - $115.99 $40,904 - $50,339
-434 Reduced 2.83%
14,892 $1.6 Million
Q4 2021

Feb 15, 2022

SELL
$94.25 - $115.99 $40,904 - $50,339
-434 Reduced 2.83%
14,892 $1.6 Million
Q3 2021

Jun 21, 2023

BUY
$80.98 - $109.47 $972,650 - $1.31 Million
12,011 Added 362.32%
15,326 $1.58 Million
Q3 2021

Mar 30, 2023

SELL
$80.98 - $109.47 $58,791 - $79,475
-726 Reduced 4.52%
15,326 $1.58 Million
Q3 2021

Nov 15, 2021

SELL
$80.98 - $109.47 $58,791 - $79,475
-726 Reduced 4.52%
15,326 $1.58 Million
Q2 2021

Jun 21, 2023

BUY
$82.78 - $101.0 $1.05 Million - $1.29 Million
12,737 Added 384.22%
16,052 $1.41 Million
Q2 2021

Mar 30, 2023

BUY
$82.78 - $101.0 $83,028 - $101,303
1,003 Added 6.66%
16,052 $1.41 Million
Q2 2021

Aug 16, 2021

BUY
$82.78 - $101.0 $1.33 Million - $1.62 Million
16,037 Added 106913.33%
16,052 $1.41 Million
Q1 2021

Jun 26, 2023

BUY
$90.71 - $108.28 $1.06 Million - $1.27 Million
11,734 Added 353.97%
15,049 $1.46 Billion
Q1 2021

Mar 30, 2023

SELL
$90.71 - $108.28 $49,255 - $58,796
-543 Reduced 3.48%
15,049 $1.46 Million
Q1 2021

May 14, 2021

SELL
$90.71 - $108.28 $1.41 Million - $1.69 Million
-15,577 Reduced 99.9%
15 $1.46 Million
Q4 2020

Jun 22, 2023

BUY
$92.08 - $124.48 $1.13 Million - $1.53 Million
12,277 Added 370.35%
15,592 $1.75 Million
Q4 2020

Mar 30, 2023

SELL
$92.08 - $124.48 $12,522 - $16,929
-136 Reduced 0.86%
15,592 $1.75 Million
Q4 2020

Feb 16, 2021

SELL
$92.08 - $124.48 $12,522 - $16,929
-136 Reduced 0.86%
15,592 $1.75 Million
Q3 2020

Jun 26, 2023

BUY
$66.45 - $92.7 $824,843 - $1.15 Million
12,413 Added 374.45%
15,728 $1.46 Million
Q3 2020

Mar 30, 2023

SELL
$66.45 - $92.7 $50,568 - $70,544
-761 Reduced 4.62%
15,728 $1.46 Million
Q3 2020

Nov 13, 2020

SELL
$66.45 - $92.7 $50,568 - $70,544
-761 Reduced 4.62%
15,728 $1.46 Million
Q2 2020

Jun 26, 2023

BUY
$57.09 - $79.27 $752,103 - $1.04 Million
13,174 Added 397.41%
16,489 $1.29 Million
Q2 2020

Mar 30, 2023

BUY
$57.09 - $79.27 $23,863 - $33,134
418 Added 2.6%
16,489 $1.29 Million
Q2 2020

Aug 14, 2020

BUY
$57.09 - $79.27 $23,863 - $33,134
418 Added 2.6%
16,489 $1.29 Million
Q1 2020

Jul 12, 2023

BUY
$48.11 - $82.22 $622,447 - $1.06 Million
12,938 Added 390.29%
16,253 $950,000
Q1 2020

Mar 30, 2023

BUY
$48.11 - $82.22 $27,711 - $47,358
576 Added 3.72%
16,071 $939,000
Q1 2020

May 15, 2020

BUY
$48.11 - $82.22 $27,711 - $47,358
576 Added 3.72%
16,071 $940,000
Q4 2019

Jul 12, 2023

BUY
$66.73 - $82.59 $812,771 - $1.01 Million
12,180 Added 367.42%
15,495 $1.24 Million
Q4 2019

Mar 30, 2023

SELL
$66.73 - $82.59 $30,562 - $37,826
-458 Reduced 2.87%
15,495 $1.24 Million
Q4 2019

Feb 14, 2020

SELL
$66.73 - $82.59 $30,562 - $37,826
-458 Reduced 2.87%
15,495 $1.24 Million
Q3 2019

Jul 12, 2023

BUY
$72.9 - $101.41 $921,310 - $1.28 Million
12,638 Added 381.24%
15,953 $1.17 Million
Q3 2019

Mar 30, 2023

BUY
$72.9 - $101.41 $107,017 - $148,869
1,468 Added 10.13%
15,953 $1.17 Million
Q3 2019

Nov 14, 2019

BUY
$72.9 - $101.41 $107,017 - $148,869
1,468 Added 10.13%
15,953 $1.17 Million
Q2 2019

Jul 12, 2023

BUY
$73.54 - $97.8 $850,122 - $1.13 Million
11,560 Added 348.72%
14,875 $1.4 Million
Q2 2019

Mar 30, 2023

BUY
$73.54 - $97.8 $87,365 - $116,186
1,188 Added 8.93%
14,485 $1.37 Million
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $87,365 - $116,186
1,188 Added 8.93%
14,485 $1.37 Million
Q1 2019

Jul 13, 2023

BUY
$48.7 - $86.6 $486,123 - $864,441
9,982 Added 301.12%
13,297 $1.06 Million
Q1 2019

Mar 30, 2023

BUY
$48.7 - $86.6 $468,494 - $833,092
9,620 Added 261.63%
13,297 $1.06 Million
Q1 2019

May 16, 2019

SELL
$48.7 - $86.6 $2.17 Million - $3.85 Million
-44,459 Reduced 76.98%
13,297 $1.06 Million
Q1 2019

May 15, 2019

BUY
$48.7 - $86.6 $2.16 Million - $3.83 Million
44,280 Added 328.58%
57,756 $1.54 Million
Q4 2018

Jul 13, 2023

BUY
$45.57 - $74.26 $463,036 - $754,555
10,161 Added 306.52%
13,476 $726,000
Q4 2018

Feb 14, 2019

BUY
$45.57 - $74.26 $478,986 - $780,546
10,511 Added 354.5%
13,476 $726,000
Q3 2018

Jul 13, 2023

BUY
$58.91 - $78.32 $598,584 - $795,809
10,161 Added 306.52%
13,476 $1.05 Billion
Q3 2018

Nov 14, 2018

SELL
$58.91 - $78.32 $619,203 - $823,221
-10,511 Reduced 78.0%
2,965 $231,000
Q1 2018

May 15, 2018

BUY
$73.28 - $102.95 $58,917 - $82,771
804 Added 6.34%
13,476 $0
Q4 2017

Feb 15, 2018

SELL
$62.91 - $88.32 $856,016 - $1.2 Million
-13,607 Reduced 51.78%
12,672 $956,000
Q3 2017

Nov 14, 2017

SELL
$42.37 - $69.67 $11,143 - $18,323
-263 Reduced 0.99%
26,279 $1.83 Million
Q2 2017

Aug 14, 2017

BUY
N/A
26,542
26,542 $1.35 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.